Learn More
Primary plasma cell leukemia (PPCL) is a rare form of disease accounting for 1–2% of myelomas. Between September 1990 and November 2000, among 540 patients with myeloma studied, 24 fulfilled the(More)
Between August 1994 and June 1999, 56 patients were prospectively randomized to receive ifosfamide 10 g/m2 + GM-CSF 5 μg/kg/day (IFO+GM-CSF n = 28) and cyclophosphamide 4 g/m2 + GM-CSF 5 μg/kg/day(More)